SHANLE SCOTT: Open Payments
NPI 1184850257 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 20 payments from 7 companies in 2025. Trend: 2023 $443 · 2024 $746 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| Novo Nordisk Inc | 4 | $90 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| PFIZER INC. | 3 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: Ozempic, FARXIGA, ELIQUIS, TRELEGY ELLIPTA, LEQVIO, AIRSUPRA, SHINGRIX, GEMTESA.
Industry payments across TN — which companies pay providers there.
